PortfoliosLab logoPortfoliosLab logo
SYK vs. EW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SYK vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SYK achieves a -6.83% return, which is significantly lower than EW's 0.96% return. Over the past 10 years, SYK has outperformed EW with an annualized return of 12.14%, while EW has yielded a comparatively lower 8.56% annualized return.


SYK

1D
-6.42%
1M
-0.26%
6M
-11.39%
YTD
-6.83%
1Y
-12.91%
3Y*
6.29%
5Y*
4.83%
10Y*
12.14%
ALL TIME*
17.55%

EW

1D
-0.98%
1M
-8.80%
6M
5.79%
YTD
0.96%
1Y
8.50%
3Y*
1.61%
5Y*
-5.18%
10Y*
8.56%
ALL TIME*
17.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$480.40M$453.68M$434.27M
$795.69M$812.11M$866.68M

SYK vs. EW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SYK
Stryker Corporation
-6.83%-1.48%21.34%23.80%-7.42%10.22%18.17%35.33%2.43%30.84%
EW
Edwards Lifesciences Corporation
0.96%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%

Correlation

The correlation between SYK and EW is 0.40, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.40

Correlation (3Y)
Balances recent behavior with more history.

0.43

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.54

Correlation (10Y)
Provides a long-term view across more market conditions.

0.56

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2000

0.44

The correlation between SYK and EW shifts across timeframes, from 0.40 (1 year) to 0.56 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SYK:

$124.86B

EW:

$49.56B

EPS

SYK:

$9.65

EW:

$1.88

PE Ratio

SYK:

33.75

EW:

45.90

PEG Ratio

SYK:

2.50

EW:

1.47

PS Ratio

SYK:

4.87

EW:

7.96

PB Ratio

SYK:

2.62

EW:

4.84

Total Revenue (TTM)

SYK:

$25.84B

EW:

$6.30B

Gross Profit (TTM)

SYK:

$16.84B

EW:

$4.92B

EBITDA (TTM)

SYK:

$6.35B

EW:

$1.44B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SYK vs. EW — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SYK
SYK Risk / Return Rank: 1717
Overall Rank
SYK Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
SYK Sortino Ratio Rank: 1717
Sortino Ratio Rank
SYK Omega Ratio Rank: 1818
Omega Ratio Rank
SYK Calmar Ratio Rank: 2222
Calmar Ratio Rank
SYK Martin Ratio Rank: 1212
Martin Ratio Rank

EW
EW Risk / Return Rank: 5656
Overall Rank
EW Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
EW Sortino Ratio Rank: 5151
Sortino Ratio Rank
EW Omega Ratio Rank: 4949
Omega Ratio Rank
EW Calmar Ratio Rank: 6161
Calmar Ratio Rank
EW Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SYK vs. EW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SYKEWDifference
Sharpe ratioReturn per unit of total volatility

-0.95

Sortino ratioReturn per unit of downside risk

-1.40

Omega ratioGain probability vs. loss probability

0.91

1.08

-0.16

Calmar ratioReturn relative to maximum drawdown

-0.59

0.65

-1.23

Martin ratioReturn relative to average drawdown

-1.28

1.51

-2.80

SYK vs. EW - Sharpe Ratio Comparison

The current SYK Sharpe Ratio is -0.60, which is lower than the EW Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of SYK and EW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SYK vs. EW - Drawdown Comparison

The maximum SYK drawdown since its inception was -58.63%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for SYK and EW.


Loading charts...

Drawdown Indicators


SYKEWDifference

Max Drawdown

Largest peak-to-trough decline

-58.63%

-54.32%

-4.31%

Max Drawdown (1Y)

Largest decline over 1 year

-27.80%

-13.19%

-14.61%

Max Drawdown (3Y)

Largest decline over 3 years

-29.45%

-37.53%

+8.08%

Max Drawdown (5Y)

Largest decline over 5 years

-31.68%

-54.32%

+22.64%

Max Drawdown (10Y)

Largest decline over 10 years

-43.80%

-54.32%

+10.52%

Current Drawdown

Current decline from peak

-18.47%

-34.14%

+15.67%

Average Drawdown

Average peak-to-trough decline

-13.13%

-14.57%

+1.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.68%

5.65%

+7.03%

Volatility

SYK vs. EW - Volatility Comparison

Stryker Corporation (SYK) has a higher volatility of 13.88% compared to Edwards Lifesciences Corporation (EW) at 7.05%. This indicates that SYK's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SYKEWDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.88%

7.05%

+6.83%

Volatility (6M)

Calculated over the trailing 6-month period

23.52%

19.74%

+3.78%

Volatility (1Y)

Calculated over the trailing 1-year period

27.28%

24.34%

+2.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.10%

32.70%

-7.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.75%

32.23%

-5.48%

Dividends

SYK vs. EW - Dividend Comparison

SYK's dividend yield for the trailing twelve months is around 1.07%, while EW has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SYK
Stryker Corporation
1.07%0.97%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%

Financials

SYK vs. EW - Financials Comparison

This section allows you to compare key financial metrics between Stryker Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

SYK vs. EW - Profitability Comparison

The chart below illustrates the profitability comparison between Stryker Corporation and Edwards Lifesciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

SYK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Stryker Corporation reported a gross profit of 4.50B and revenue of 6.59B. Therefore, the gross margin over that period was 68.3%.

EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.

SYK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Stryker Corporation reported an operating income of 1.66B and revenue of 6.59B, resulting in an operating margin of 25.2%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.

SYK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Stryker Corporation reported a net income of 1.28B and revenue of 6.59B, resulting in a net margin of 19.4%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.


Frequently Asked Questions


SYK and EW have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SYK has higher volatility (13.88%) compared to EW (7.05%). In terms of maximum drawdown, SYK dropped -58.63% vs EW's -54.32%.

EW currently has the higher Sharpe Ratio (0.35 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SYK and EW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer